Astrana Health Inc.

Valuation Analysis

About the Company

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in Fe

Astrana Health Inc. Stock at a Glance

Astrana Health Inc. (ASTH) is currently trading at $38.62 with a market capitalization of $1.9B. The trailing P/E ratio stands at 63.31x, with a forward P/E of 11.33x. The 52-week range spans from $18.08 to $40.13; the current price is 3.8% below the yearly high. Year-over-year revenue growth stands at +55.6%. The net profit margin stands at 0.86%.

💰 Dividend

Astrana Health Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

9 analysts rate Astrana Health Inc. (ASTH) on consensus: Strong Buy. The average price target is $46.00, implying +19.11% from the current price. Analyst price targets range from $41.00 to $50.00.

Astrana Health Inc.: The Investment Case in Detail

Astrana Health Inc. (ASTH) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Top-line momentum is unusually strong with revenue expanding 55.6% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind. Wall Street consensus sits at Strong Buy with an average price target implying roughly 19.11% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

With a net margin of just 0.86%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

What to Watch Next

• The forward P/E of 11.33x is meaningfully below the trailing 63.31x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 93.2% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (9.22%), higher leverage relative to equity.

Trading Data

Related Stocks in the Same Sector

Where can I buy Astrana Health Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.